366 related articles for article (PubMed ID: 31819182)
1. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells.
Hu C; Pang B; Lin G; Zhen Y; Yi H
Br J Cancer; 2020 Jan; 122(1):23-29. PubMed ID: 31819182
[TBL] [Abstract][Full Text] [Related]
2. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
Wang Y; Jia A; Bi Y; Wang Y; Liu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
Li X; Li Y; Yu Q; Qian P; Huang H; Lin Y
J Leukoc Biol; 2021 Aug; 110(2):257-270. PubMed ID: 34075637
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
6. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
7. Connections between Metabolism and Epigenetic Modification in MDSCs.
Dai H; Xu H; Wang S; Ma J
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
[TBL] [Abstract][Full Text] [Related]
8. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment.
Ou X; Lv W
Future Oncol; 2020 Mar; 16(8):383-393. PubMed ID: 32067476
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
[TBL] [Abstract][Full Text] [Related]
12. The immunobiology of myeloid-derived suppressor cells in cancer.
Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
14. The essential link: How STAT3 connects tumor metabolism to immunity.
Zhong S; Tong J
Biochim Biophys Acta Gene Regul Mech; 2024 Jun; 1867(2):195028. PubMed ID: 38636823
[TBL] [Abstract][Full Text] [Related]
15. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
De Cicco P; Ercolano G; Ianaro A
Front Immunol; 2020; 11():1680. PubMed ID: 32849585
[TBL] [Abstract][Full Text] [Related]
16. Plasticity and biological diversity of myeloid derived suppressor cells.
Ben-Meir K; Twaik N; Baniyash M
Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
[TBL] [Abstract][Full Text] [Related]
17. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
18. In Brief: Myeloid-derived suppressor cells in cancer.
Solito S; Pinton L; Mandruzzato S
J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in cancer and cancer therapy.
Lasser SA; Ozbay Kurt FG; Arkhypov I; Utikal J; Umansky V
Nat Rev Clin Oncol; 2024 Feb; 21(2):147-164. PubMed ID: 38191922
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
Pyzer AR; Cole L; Rosenblatt J; Avigan DE
Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]